Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112816495 | 11281649 | 5 | F | 20160701 | 20150717 | 20160707 | EXP | PR-ABBVIE-15P-131-1425335-00 | ABBVIE | 0.00 | N | F | Y | 0.00000 | 20160707 | OT | COUNTRY NOT SPECIFIED | PR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112816495 | 11281649 | 1 | PS | NORVIR | RITONAVIR | 1 | Transplacental | UNKNOWN | 20945 | ||||||||||
| 112816495 | 11281649 | 2 | SS | REYATAZ | ATAZANAVIR SULFATE | 1 | Transplacental | UNKNOWN | 0 | ||||||||||
| 112816495 | 11281649 | 3 | SS | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Transplacental | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112816495 | 11281649 | 1 | Maternal exposure timing unspecified |
| 112816495 | 11281649 | 2 | Maternal exposure timing unspecified |
| 112816495 | 11281649 | 3 | Maternal exposure timing unspecified |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112816495 | 11281649 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112816495 | 11281649 | Cleft lip | |
| 112816495 | 11281649 | Foetal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |